LFWD (Lifeward) Valuation Rank


LFWD Lifeward Ltd LFWD
56 GF Score
Price $6.87
GF Value $13.73
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Lifeward Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Lifeward Valuation Rank Related Terms

LFWD
56GF Score
Lifeward Ltd LFWD
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lifeward (LFWD) Overvalued in 2026?

Based on GuruFocus' analysis, Lifeward stock appears to be undervalued. The current stock price of $6.87 is trading 50% below its estimated GF Value™ of $13.73. GuruFocus considers Lifeward to be Possible Value Trap.

Key valuation signals for LFWD:

  • Valuation Rank:
  • GF Value™: $13.73 vs. price of $6.87 (50% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the LFWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifeward Business Description

Address 2 Cabot Road, Hudson, MA, USA, 01749
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
56GF Score

Get the complete analysis for LFWD

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.87
Price
$13.73
GF Value